Dual use of antifungals in medicine and agriculture: How do we help prevent resistance developing in human pathogens?
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 347 KB, PDF document
Azole resistance in Aspergillus fumigatus is a One Health resistance threat, where azole fungicide exposure compromises the efficacy of medical azoles. The use of the recently authorized fungicide ipflufenoquin, which shares its mode-of-action with a new antifungal olorofim, underscores the need for risk assessment for dual use of antifungals.
Original language | English |
---|---|
Article number | 100885 |
Journal | Drug Resistance Updates |
Volume | 65 |
ISSN | 1368-7646 |
DOIs | |
Publication status | Published - 2022 |
Bibliographical note
Publisher Copyright:
© 2022 The Authors
- Aspergillus fumigatus, DHODH inhibitor, olorofim, One Health, triazole resistance
Research areas
ID: 323986099